Mutational and phylogenetic analyses of the mycobacterial mbt gene cluster

Journal of Bacteriology

Volumn 193, Issue 21, 2011, Pages 5905-5913

  Chavadi, Sivagami Sundaram ^a   Stirrett, Karen L ^b,c   Edupuganti, Uthamaphani R ^a   Vergnolle, Olivia ^a   Sadhanandan, Gigani ^b,d   Marchiano, Emily ^b,e   Martin, Che ^a   Qiu, Wei Gang ^a   Soll, Clifford E ^a   Quadri, Luis E N ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Southeastern Community College   (United States)

^d NEW YORK METHODIST HOSPITAL   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PROTEIN MYCOBACTIN; SIDEROPHORE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BIOSYNTHESIS; GENE CLUSTER; GENE DELETION; GENE TRANSFER; MBT GENE; MUTATIONAL ANALYSIS; MYCOBACTERIUM; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS;

BACTERIAL PROTEINS; BIOSYNTHETIC PATHWAYS; CONSERVED SEQUENCE; DNA MUTATIONAL ANALYSIS; GENE ORDER; MULTIGENE FAMILY; MYCOBACTERIUM SMEGMATIS; OXAZOLES; PHYLOGENY;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 80055040931     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.05811-11     Document Type: Article

References (52)

1. Billman-Jacobe, H., M. J. McConville, R. E. Haites, S. Kovacevic, and R. L. Coppel. 1999. Identification of a peptide synthetase involved in the biosynthesis of glycopeptidolipids of Mycobacterium smegmatis. Mol. Microbiol. 33:1244-1253.
2. Brown-Elliott, B. A., J. M. Brown, P. S. Conville, and R. J. Wallace, Jr. 2006. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin. Microbiol. Rev. 19:259-282.
3. Chavadi, S. S., et al. 2011. Inactivation of tesA reduces cell-wall lipid production and increases drug susceptibility in mycobacteria. J. Biol. Chem. 286:24616-24625.
4. Claxton, H. B., D. L. Akey, M. K. Silver, S. J. Admiraal, and J. L. Smith. 2009. Structure and functional analysis of RifR, the type II thioesterase from the rifamycin biosynthetic pathway. J. Biol. Chem. 284:5021-5029.
5. De Voss, J. J., K. Rutter, B. G. Schroeder, and C. E. Barry III. 1999. Iron acquisition and metabolism by mycobacteria. J. Bacteriol. 181:4443-4451.
6. De Voss, J. J., et al. 2000. The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc. Natl. Acad. Sci. U. S. A. 97:1252-1257.
7. Felnagle, E. A., et al. 2010. MbtH-like proteins as integral components of bacterial nonribosomal peptide synthetases. Biochemistry 49:8815-8817.
8. Fennell, K. A., U. Mollmann, and M. J. Miller. 2008. Syntheses and biological activity of amamistatin B and analogs. J. Org. Chem. 73:1018-1024.
9. Ferreras, J. A., J. S. Ryu, F. Di Lello, D. S. Tan, and L. E. Quadri. 2005. Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis. Nat. Chem. Biol. 1:29-32.
10. Ferreras, J. A., et al. 2008. Mycobacterial phenolic glycolipid virulence factor biosynthesis: mechanism and small-molecule inhibition of polyketide chain initiation. Chem. Biol. 15:51-61.
11. Fiss, E. H., S. Yu, and W. R. Jacobs, Jr. 1994. Identification of genes involved in the sequestration of iron in mycobacteria: the ferric exochelin biosynthetic and uptake pathways. Mol. Microbiol. 14:557-569.
12. Harrison, A. J., et al. 2006. The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin, reveals it to be a salicylate synthase. J. Bacteriol. 188:6081-6091.
13. Heathcote, M. L., J. Staunton, and P. F. Leadlay. 2001. Role of type II thioesterases: evidence for removal of short acyl chains produced by aberrant decarboxylation of chain extender units. Chem. Biol. 8:207-220.
14. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
15. Huelsenbeck, J. P., F. Ronquist, R. Nielsen, and J. P. Bollback. 2001. Bayesian inference of phylogeny and its impact on evolutionary biology. Science 294:2310-2314.
16. Ikeda, Y., T. Furumai, and Y. Igarashi. 2005. Nocardimicins G, H and I, siderophores with muscarinic M3 receptor binding inhibitory activity from Nocardia nova JCM 6044. J. Antibiot. (Tokyo) 58:566-572.
17. Ikeda, Y., H. Nonaka, T. Furumai, H. Onaka, and Y. Igarashi. 2005. Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674. J. Nat. Prod. 68:1061-1065.
18. Imker, H. J., D. Krahn, J. Clerc, M. Kaiser, and C. T. Walsh. 2010. N-Acylation during glidobactin biosynthesis by the tridomain nonribosomal peptide synthetase module GlbF. Chem. Biol. 17:1077-1083.
19. Jeevarajah, D., J. H. Patterson, M. J. McConville, and H. Billman-Jacobe. 2002. Modification of glycopeptidolipids by an O-methyltransferase of Mycobacterium smegmatis. Microbiology 148:3079-3087.
20. Kim, B. S., T. A. Cropp, B. J. Beck, D. H. Sherman, and K. A. Reynolds. 2002. Biochemical evidence for an editing role of thioesterase II in the biosynthesis of the polyketide pikromycin. J. Biol. Chem. 277:48028-48034.
21. Larkin, M. A., et al. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948.
22. Lautru, S., D. Oves-Costales, J. L. Pernodet, and G. L. Challis. 2007. MbtHlike protein-mediated cross-talk between non-ribosomal peptide antibiotic and siderophore biosynthetic pathways in Streptomyces coelicolor M145. Microbiology 153:1405-1412.
23. Lerat, E., V. Daubin, H. Ochman, and N. A. Moran. 2005. Evolutionary origins of genomic repertoires in bacteria. PLoS Biol. 3:e130.
24. Macham, L. P., M. C. Stephenson, and C. Ratledge. 1977. Iron transport in Mycobacterium smegmatis: the isolation, purification and function of exochelin MS. J. Gen. Microbiol. 101:41-49.
25. Minero, M. V., et al. 2009. Nocardiosis at the turn of the century. Medicine (Baltimore) 88:250-261.
26. Mitchell, J. M., and J. T. Shaw. 2007. Synthesis and stereochemical assignment of brasilibactin A. Org. Lett. 9:1679-1681.
27. Moody, D. B., et al. 2004. T cell activation by lipopeptide antigens. Science 303:527-531.
28. Moreno-Hagelsieb, G., and K. Latimer. 2008. Choosing BLAST options for better detection of orthologs as reciprocal best hits. Bioinformatics 24:319-324.
29. Murakami, Y., et al. 1996. Formobactin, a novel free radical scavenging and neuronal cell protecting substance from Nocardia sp. J. Antibiot. (Tokyo) 49:839-845.
30. Onwueme, K. C., J. A. Ferreras, J. Buglino, C. D. Lima, and L. E. Quadri. 2004. Mycobacterial polyketide-associated proteins are acyltransferases:proof of principle with Mycobacterium tuberculosis PapA5. Proc. Natl. Acad. Sci. U. S. A. 101:4608-4613.
31. Parish, T., and N. G. Stoker (ed.). 1998. Mycobacteria protocols, vol. 101. Humana Press, Totowa, NJ.
32. Parish, T., and N. G. Stoker. 2000. Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 146:1969-1975.
33. Quadri, L. E. N. 2000. Assembly of aryl-capped siderophores by modular peptide synthetases and polyketide synthases. Mol. Microbiol. 37:1-12.
34. Quadri, L. E. N. 2007. Strategic paradigm shifts in the antimicrobial drug discovery process of the 21st century. Infect. Disord. Drug Targets 7:230-237.
35. Quadri, L. E. N., and C. Ratledge. 2005. Iron metabolism in the tubercle bacillus and other mycobacteria, p. 341-357. In S. T. Cole, K. D. Eisenach, D. N. McMurray, and W. R. J. Jacobs (ed.), Tuberculosis and the tubercle bacillus. ASM Press, Washington, DC.
36. Quadri, L. E. N., J. Sello, T. A. Keating, P. H. Weinreb, and C. T. Walsh. 1998. Identification of a Mycobacterium tuberculosis gene cluster encoding the biosynthetic enzymes for assembly of the virulence-conferring siderophore mycobactin. Chem. Biol. 5:631-645.
37. Ratledge, C., and G. A. Snow. 1974. Isolation and structure of nocobactin NA, a lipid-soluble iron-binding compound from Nocardia asteroides. Biochem. J. 139:407-413.
38. Recht, J., A. Martinez, S. Torello, and R. Kolter. 2000. Genetic analysis of sliding motility in Mycobacterium smegmatis. J. Bacteriol. 182:4348-4851.
39. Rodriguez, G. M., and I. Smith. 2006. Identification of an ABC transporter required for iron acquisition and virulence in Mycobacterium tuberculosis. J. Bacteriol. 188:424-430.
40. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
41. Schwarzer, D., H. D. Mootz, U. Linne, and M. A. Marahiel. 2002. Regeneration of misprimed nonribosomal peptide synthetases by type II thioesterases. Proc. Natl. Acad. Sci. U. S. A. 99:14083-14088.
42. Stirrett, K. L., et al. 2008. Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis. Bioorg. Med. Chem. Lett. 18:2662-2668.
43. Suenaga, K., S. Kokubo, C. Shinohara, T. Tsuji, and D. Uemura. 1999. Structures of amamistatins A and B, novel growth inhibitors of human tumor cell lines from an actinomycete. Tetrahedron Lett. 40:1945-1948.
44. Tortoli, E. 12 June 2011. Phylogeny of the genus Mycobacterium: many doubts, few certainties. Infect. Genet. Evol. [Epub ahead of print.] doi:10.1016/j.meegid.2011.05.025.
45. Treangen, T. J., and E. P. Rocha. 2011. Horizontal transfer, not duplication, drives the expansion of protein families in prokaryotes. PLoS Genet. 7:e1001284.
46. Tsuda, M., et al. 2005. Brasilibactin A, a cytotoxic compound from actinomycete Nocardia brasiliensis. J. Nat. Prod. 68:462-464.
47. Tsukamoto, M., et al. 1997. BE-32030 A, B, C, D and E, new antitumor substances produced by Nocardia sp. A32030. J. Antibiot. (Tokyo) 50:815-821.
48. Tullius, M. V., G. Harth, S. Maslesa-Galic, B. J. Dillon, and M. A. Horwitz. 2008. A replication-limited recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG. Infect. Immun. 76:5200-5214.
49. Wolpert, M., B. Gust, B. Kammerer, and L. Heide. 2007. Effects of deletions of mbtH-like genes on clorobiocin biosynthesis in Streptomyces coelicolor. Microbiology 153:1413-1423.
50. Yu, S., E. Fiss, and W. R. Jacobs, Jr. 1998. Analysis of the exochelin locus in Mycobacterium smegmatis: biosynthesis genes have homology with genes of the peptide synthetase family. J. Bacteriol. 180:4676-4685.
51. Zhang, W., J. R. Heemstra, Jr., C. T. Walsh, and H. J. Imker. 2010. Activation of the pacidamycin PacL adenylation domain by MbtH-like proteins. Biochemistry 49:9946-9947.
52. Zhu, W., et al. 1998. Exochelin genes in Mycobacterium smegmatis: identification of an ABC transporter and two non-ribosomal peptide synthetase genes. Mol. Microbiol. 29:629-639.